Dynamic PET/CT imaging of 18 F-(2 S , 4 R )4-fluoroglutamine in healthy volunteers and oncological patients

Conclusions18F-FGln images may further supplement the diagnostic ability of18F-FDG in cancer patients and detect metabolic changes in different tumors. Furthermore, the imaging time for18F-FGln PET/CT needs to be optimized for different cancer types to improve the contrast resolution of tumors.
Source: European Journal of Nuclear Medicine and Molecular Imaging - Category: Nuclear Medicine Source Type: research